SETTLEMENT AND REDEMPTION OF ALL OUTSTANDING YORKVILLE CONVERTIBLE BONDS

Settlement and redemption of convertible bonds with Yorkville ENG Removes potentially dilutive instrument Strengthened balance sheet supports future growth

Visit Page

ADMISSION AND FIRST DAY OF DEALINGS ON AIM

Novacyt admission and first day of dealings AIM ENG Paris, France and Cambridge, UK – 1st November 2017 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce the admission of the Company’s Shares (the “Enlarged Share Capital”) to trading on AIM, a market operated by the London

Visit Page

PROPOSED ADMISSION TO TRADING ON AIM AND SUCCESSFUL CONDITIONAL CAPITAL RAISE OF €9.7 MILLION

Novacyt proposed admission to AIM ENG Paris, France and Cambridge, UK – 18th October 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces that it has raised a total of €9.7 million (before expenses) through a conditional placing (the “Placing”) of 7,051,590 new shares (the “Placing Shares”), raising €4.7 million, and

Visit Page